NuvoAir says it experienced 500 percent growth last quarter alone, attributing much of its success lately to the pandemic, which caused demand for virtual care to increase. The company will use this fresh funding to expand its services globally and develop new products.
E25Bio, a company that develops rapid diagnostic tests for infectious diseases, announced Wednesday that it had raised $2 million to develop tests for the novel coronavirus.